Trial Profile
Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Jun 2015
Price :
$35
*
At a glance
- Drugs Ondansetron (Primary)
- Indications Vomiting
- Focus Pharmacokinetics
- 19 Jun 2015 New trial record